Sfoglia per Autore
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma
2017-01-01 Massihnia D.; Funel N.; Leon L.; Castiglia M.; Perez A.; Barraco N.; Listi A.; Galvano A.; Passiglia F.; Guarini A.; Calo V.; Rizzo S.; Castellana L.; Giovannetti E.; Russo A.
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1HIndole derivatives as new anticancer agents in the treatment of pancreatic ductal adenocarcinoma
2020-01-01 Cascioferro S.; Li Petri G. ; Parrino B.; El Hassouni B.; Carbone D.; Arizza V.; Perricone U.; Padova A.; Funel N.; Peters G.J.; Cirrincione G.; Giovannetti E.; Diana P.
Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development
2023-01-01 Pecoraro, C.; Terrana, F.; Panzeca, G.; Parrino, B.; Cascioferro, S.; Diana, P.; Giovannetti, E.; Carbone, D.
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
2023-07-19 Carbone, Daniela; Pecoraro, Camilla; Panzeca, Giovanna; Xu, Geng; Roeten, Margot S F; Cascioferro, Stella; Giovannetti, Elisa; Diana, Patrizia; Parrino, Barbara
Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma
2024-03-01 Sciano F.; Terrana F.; Pecoraro C.; Parrino B.; Cascioferro S.; Diana P.; Giovannetti E.; Carbone D.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile